TD Cowen Downgrades Oak Street Health to Market Perform, Raises Price Target to $39
TD Cowen analyst Gary Taylor downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform and raises the price target from $34 to $39.
Bernstein Downgrades Oak Street Health to Market Perform, Raises Price Target to $39
Bernstein analyst Lance Wilkes downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform and raises the price target from $35 to $39.
Raymond James Downgrades Oak Street Health to Market Perform
Raymond James analyst John Ransom downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform.
Jefferies Downgrades Oak Street Health to Hold
Jefferies analyst Brian Tanquilut downgrades Oak Street Health (NYSE:OSH) from Buy to Hold.
Expert Ratings for Oak Street Health
Over the past 3 months, 7 analysts have published their opinion on Oak Street Health (NYSE:OSH) stock. These…
SVB Leerink Maintains Market Perform on Oak Street Health, Raises Price Target to $39
SVB Leerink analyst Whit Mayo maintains Oak Street Health (NYSE:OSH) with a Market Perform and raises the price target from $33 to $39.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Lixte Biotech Hldgs (NASDAQ:LIXT) shares rose 97.3% to $1.6 during Tuesday’s regular session. Trading volume for this…
Oak Street Health States That Its Policy Is Not To Comment On Unusual Market Activity
Oak Street Health, Inc.
US Stocks Pause As Traders Await Powell’s Speech: Analyst Warns Of Retest Of October Lows As Market, Economic Data Conspire Against Monetary Policy
Stocks look set for another nervous session on Tuesday as traders look ahead to comments from Fed Chair Jerome Powell and another batch of earnings reports.
Cues From Monday’s Trading: